Evogene (EVGN) Misses Q2 EPS by 24c

Evogene (NASDAQ: EVGN) reported Q2 EPS of ($0.85), $0.24 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $880 thousand versus the consensus estimate of $1.69 million.

For earnings history and earnings-related data on Evogene (EVGN) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Morgan Stanley Resumes OMV AG (OMV:AV) (OMVKY) at Equalweight
• Berenberg Starts Brooks Macdonald Group PLC (BRK:LN) at Buy